Trial intelligence / Profile preview

Serratus Plane Block in Minimally Invasive Mitral Valve Repair

NCT05648266Completed

Sponsor
University Medical Center Hamburg-Eppendorf
Start
Apr 2022
Primary completion
Jul 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by University Medical Center Hamburg-Eppendorf. Primary endpoint: Numeric Rating Scale at 48 hours. Started Apr 2022; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05648266.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05648266.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call